SCHRODINGER INC (SDGR) Stock Fundamental Analysis

NASDAQ:SDGR • US80810D1037

11.63 USD
+0.23 (+2.02%)
At close: Feb 17, 2026
11.5092 USD
-0.12 (-1.04%)
After Hours: 2/17/2026, 8:00:02 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to SDGR. SDGR was compared to 35 industry peers in the Health Care Technology industry. No worries on liquidiy or solvency for SDGR as it has an excellent financial health rating, but there are worries on the profitability. SDGR is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • In the past year SDGR has reported negative net income.
  • In the past year SDGR has reported a negative cash flow from operations.
  • In the past 5 years SDGR reported 4 times negative net income.
  • SDGR had negative operating cash flow in 4 of the past 5 years.
SDGR Yearly Net Income VS EBIT VS OCF VS FCFSDGR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 -50M -100M -150M -200M

1.2 Ratios

  • The Return On Assets of SDGR (-26.92%) is comparable to the rest of the industry.
  • SDGR has a Return On Equity (-54.77%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -26.92%
ROE -54.77%
ROIC N/A
ROA(3y)-13.11%
ROA(5y)-11.18%
ROE(3y)-23.43%
ROE(5y)-18.45%
ROIC(3y)N/A
ROIC(5y)N/A
SDGR Yearly ROA, ROE, ROICSDGR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 -10 -20 -30 -40

1.3 Margins

  • The Gross Margin of SDGR (58.16%) is comparable to the rest of the industry.
  • In the last couple of years the Gross Margin of SDGR has grown nicely.
  • The Profit Margin and Operating Margin are not available for SDGR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 58.16%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.19%
GM growth 5Y2.08%
SDGR Yearly Profit, Operating, Gross MarginsSDGR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. Health

2.1 Basic Checks

  • SDGR does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • SDGR has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, SDGR has more shares outstanding
  • There is no outstanding debt for SDGR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
SDGR Yearly Shares OutstandingSDGR Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
SDGR Yearly Total Debt VS Total AssetsSDGR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

  • SDGR has an Altman-Z score of 0.26. This is a bad value and indicates that SDGR is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 0.26, SDGR is in line with its industry, outperforming 48.57% of the companies in the same industry.
  • SDGR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 0.26
ROIC/WACCN/A
WACC9.43%
SDGR Yearly LT Debt VS Equity VS FCFSDGR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

  • A Current Ratio of 3.25 indicates that SDGR has no problem at all paying its short term obligations.
  • SDGR has a better Current ratio (3.25) than 68.57% of its industry peers.
  • SDGR has a Quick Ratio of 3.25. This indicates that SDGR is financially healthy and has no problem in meeting its short term obligations.
  • SDGR has a Quick ratio of 3.25. This is in the better half of the industry: SDGR outperforms 68.57% of its industry peers.
Industry RankSector Rank
Current Ratio 3.25
Quick Ratio 3.25
SDGR Yearly Current Assets VS Current LiabilitesSDGR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • The Earnings Per Share has been growing slightly by 0.82% over the past year.
  • Looking at the last year, SDGR shows a very strong growth in Revenue. The Revenue has grown by 32.90%.
  • The Revenue has been growing by 19.41% on average over the past years. This is quite good.
EPS 1Y (TTM)0.82%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%13.46%
Revenue 1Y (TTM)32.9%
Revenue growth 3Y14.6%
Revenue growth 5Y19.41%
Sales Q2Q%53.94%

3.2 Future

  • SDGR is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 12.14% yearly.
  • Based on estimates for the next years, SDGR will show a quite strong growth in Revenue. The Revenue will grow by 18.99% on average per year.
EPS Next Y19.01%
EPS Next 2Y17.73%
EPS Next 3Y15.47%
EPS Next 5Y12.14%
Revenue Next Year24.67%
Revenue Next 2Y22%
Revenue Next 3Y18.5%
Revenue Next 5Y18.99%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
SDGR Yearly Revenue VS EstimatesSDGR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 500M 1B 1.5B
SDGR Yearly EPS VS EstimatesSDGR Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -1 -2

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • SDGR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SDGR. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SDGR Price Earnings VS Forward Price EarningsSDGR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SDGR Per share dataSDGR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4

4.3 Compensation for Growth

  • A more expensive valuation may be justified as SDGR's earnings are expected to grow with 15.47% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y17.73%
EPS Next 3Y15.47%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • SDGR does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

SCHRODINGER INC

NASDAQ:SDGR (2/17/2026, 8:00:02 PM)

After market: 11.5092 -0.12 (-1.04%)

11.63

+0.23 (+2.02%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)11-05
Earnings (Next)02-25
Inst Owners109.2%
Inst Owner Change0.23%
Ins Owners2.64%
Ins Owner Change-0.06%
Market Cap856.67M
Revenue(TTM)256.95M
Net Income(TTM)-175.99M
Analysts81.25
Price Target25.5 (119.26%)
Short Float %17.35%
Short Ratio9.02
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)31.11%
Min EPS beat(2)24.66%
Max EPS beat(2)37.55%
EPS beat(4)2
Avg EPS beat(4)6.54%
Min EPS beat(4)-28.59%
Max EPS beat(4)37.55%
EPS beat(8)5
Avg EPS beat(8)6.18%
EPS beat(12)8
Avg EPS beat(12)16.99%
EPS beat(16)10
Avg EPS beat(16)13.2%
Revenue beat(2)2
Avg Revenue beat(2)3.27%
Min Revenue beat(2)3.23%
Max Revenue beat(2)3.3%
Revenue beat(4)4
Avg Revenue beat(4)4.36%
Min Revenue beat(4)3.23%
Max Revenue beat(4)6.83%
Revenue beat(8)5
Avg Revenue beat(8)-0.23%
Revenue beat(12)7
Avg Revenue beat(12)1.23%
Revenue beat(16)11
Avg Revenue beat(16)6.23%
PT rev (1m)-8.16%
PT rev (3m)-7.79%
EPS NQ rev (1m)-3.98%
EPS NQ rev (3m)19.23%
EPS NY rev (1m)-0.12%
EPS NY rev (3m)12.65%
Revenue NQ rev (1m)0.19%
Revenue NQ rev (3m)3.61%
Revenue NY rev (1m)0.18%
Revenue NY rev (3m)0.96%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.33
P/FCF N/A
P/OCF N/A
P/B 2.67
P/tB 2.71
EV/EBITDA N/A
EPS(TTM)-2.41
EYN/A
EPS(NY)-1.58
Fwd EYN/A
FCF(TTM)-0.05
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS3.49
BVpS4.36
TBVpS4.3
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -26.92%
ROE -54.77%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 58.16%
FCFM N/A
ROA(3y)-13.11%
ROA(5y)-11.18%
ROE(3y)-23.43%
ROE(5y)-18.45%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.19%
GM growth 5Y2.08%
F-Score3
Asset Turnover0.39
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 35.82%
Cap/Sales 0.88%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.25
Quick Ratio 3.25
Altman-Z 0.26
F-Score3
WACC9.43%
ROIC/WACCN/A
Cap/Depr(3y)181.56%
Cap/Depr(5y)173.13%
Cap/Sales(3y)4.71%
Cap/Sales(5y)4.34%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0.82%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%13.46%
EPS Next Y19.01%
EPS Next 2Y17.73%
EPS Next 3Y15.47%
EPS Next 5Y12.14%
Revenue 1Y (TTM)32.9%
Revenue growth 3Y14.6%
Revenue growth 5Y19.41%
Sales Q2Q%53.94%
Revenue Next Year24.67%
Revenue Next 2Y22%
Revenue Next 3Y18.5%
Revenue Next 5Y18.99%
EBIT growth 1Y21.88%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year31.56%
EBIT Next 3Y18.65%
EBIT Next 5YN/A
FCF growth 1Y97.52%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y99.1%
OCF growth 3YN/A
OCF growth 5YN/A

SCHRODINGER INC / SDGR FAQ

What is the ChartMill fundamental rating of SCHRODINGER INC (SDGR) stock?

ChartMill assigns a fundamental rating of 3 / 10 to SDGR.


What is the valuation status for SDGR stock?

ChartMill assigns a valuation rating of 0 / 10 to SCHRODINGER INC (SDGR). This can be considered as Overvalued.


What is the profitability of SDGR stock?

SCHRODINGER INC (SDGR) has a profitability rating of 1 / 10.